Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,121.02
(
0.44%
)
Dow Jones
46,993.26
(
0.10%
)
Brent Oil
100.65
(
2.39%
)
Bitcoin
74,322.77
(
-0.70%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122793
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: kris_kade post# 89469

Friday, 01/22/2010 8:46:49 PM

Friday, January 22, 2010 8:46:49 PM

Post# of 257253

…with NVS releasing news of starting to set the pricing on the [Lovenox] generic…

Actually, NVS did no such thing; rather, a sell-side analyst issued a statement alleging that NVS was “setting prices and soliciting pre-orders” (#msg-45787228).

In any event, this is hardly news inasmuch as NVS has said on several occasions that it is ready for immediate launch as soon as FDA approval is obtained. Being ready to launch immediately requires the establishment of a distribution chain, which entails having agreements in place about pricing and volume.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now